Stryker said reported net sales for Q2 2025 increased 11.1% to $6.0 billion, and organic net sales increased 10.2%. The company said organic growth included 9.7% from increased unit volume and 0.5% from higher prices.

1. 01

   Stryker said reported net sales for Q2 2025 increased 11.1% to $6.0 billion, and organic net sales increased 10.2%. The company said organic growth included 9.7% from increased unit volume and 0.5% from higher prices.

2. 02

   The company said reported net earnings for Q2 increased 7.2% to $884 million, and diluted earnings per share were $2.29. Adjusted diluted earnings per share, excluding certain items, increased 11.4% to $3.13.

3. 03

   Stryker disclosed that operating cash flow for the 6 months of 2025 was $1,361 million. For the same period, the company spent $4,814 million on acquisitions, net of cash acquired, and net borrowings of debt were $2,331 million.

4. 04

   The company raised its full-year 2025 guidance, saying it now expects organic net sales growth of 9.5% to 10.0% and adjusted diluted earnings per share in the range of $13.40 to $13.60. Stryker also said it estimates the net impact from tariffs in 2025 at approximately $175 million.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.